Zobrazeno 1 - 10
of 66
pro vyhledávání: '"S M Crawford"'
Autor:
A. Yellowlees, K. Benstead, Stephen Chan, Robert C. F. Leonard, R. Matthew, D. Adamson, S M Crawford, R. Grieve, Janine Mansi, Catriona Keerie
Publikováno v:
Annals of Oncology. 26:2437-2441
Guidelines on the use of haematopoietic colony-stimulating factors for patients having adjuvant chemotherapy for breast cancer are designed to minimise the risk of neutropaenic infection (Smith TJ, Khatcheressian J, Lyman GH et al. Update of recommen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a8a30d30e88da115c49f65a91f94386
https://doi.org/10.1093/annonc/mdv389
https://doi.org/10.1093/annonc/mdv389
Publikováno v:
The Astronomical Journal. 135:2095-2107
We investigate three embedded massive star-forming regions using the Near-Infrared Imager (NIRIM) camera on the 3.5 m WIYN telescope. We report J-, H-, and K'-band photometry in the clusters AFGL437, AFGL5180, and AFGL5142, and use these results to p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb23235bc5a468dad1286048a0b01cd7
https://doi.org/10.1088/0004-6256/135/6/2095
https://doi.org/10.1088/0004-6256/135/6/2095
Autor:
S. M. Crawford, J. Peace
Publikováno v:
Annals of Oncology. 16:47-50
The tumour marker CA125 is an important indicator of the clinical progress of women with carcinoma of the ovary. We have investigated the interval from the nadir CA125 value to progression defined by rising CA125 (time to biochemical progression, TBP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::407aeac194a35272f0255a11f99ff726
https://doi.org/10.1093/annonc/mdi012
https://doi.org/10.1093/annonc/mdi012
Publikováno v:
British Journal of Cancer
The treatment of metastatic or advanced breast cancer has evolved over the last few years, and in the 1990s this was largely due to the introduction of the taxane family of drugs. Docetaxel (taxotere) is a semisynthetic taxane derived from 10-deacety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e598ff314110f685a7fb7db6b1c9b6f4
http://europepmc.org/articles/PMC2409488
http://europepmc.org/articles/PMC2409488
Autor:
C. E. Round, M D Peake, P.P. Melling, A C Hatfield, M F Muers, R A Haward, S M Crawford, C J Storer
Publikováno v:
British Journal of Cancer
The purpose of this study was to find out what proportion of patients are referred as lung cancer guidelines assume, whether different referral pathways result in different management and what proportion of patients are seen within recommended time i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d1221a7d41cff5e0718780c1091077f
https://doi.org/10.1038/sj.bjc.6600029
https://doi.org/10.1038/sj.bjc.6600029
Publikováno v:
European Respiratory Journal. 10:397-403
We wished to confirm that, in patients with lung cancer, trends in demography and histology, together with modest improvements in survival, first seen in the 1976-1983 cohorts, continued to 1990. All lung cancer patients resident in Yorkshire are not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae8456f5ec3a85f42bde644d79780fa5
https://doi.org/10.1183/09031936.97.10020397
https://doi.org/10.1183/09031936.97.10020397
Autor:
Allan B. MacLean, CR Lewis, Stan B. Kaye, Derek Cruickshank, S. M. Crawford, J. Kennedy, David E. Parkin, James Paul, Henry C Kitchener, T. K. Sarkar, N. S. Reed, H.K. Gordon, M. Soukop, R. Atkinson, R P Symonds, Jim Cassidy, I. D. Duncan, E M Rankin, J. Davis
Publikováno v:
Journal of Clinical Oncology. 14:2113-2119
PURPOSE In 1992, we reported the first results of a randomized study in ovarian cancer, comprising two doses of cisplatin and indicated a significant difference (P = .0008) in median survival. Four years later, we now describe the results of this tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1628d763798a1d1ca31a365626ede196
https://doi.org/10.1200/jco.1996.14.7.2113
https://doi.org/10.1200/jco.1996.14.7.2113
Autor:
R.K. Agrawal, R Cf Leonard, Elena Provenzano, Peter Simmonds, Sarah Jordan, S M Crawford, Robert Grieve, S. Bathers, David Cameron, Carlos Caldas, J Ms Bartlett, Fiona M. Blows, D.W. Rea, Louise Hiller, I. N. Fernando, Karen McAdam, Sarah Bowden, P Pharoah, Janine Mansi, Helena M. Earl, David Spooner, Janet A. Dunn, Alison F. Munro, Andrew Stanley, L. Foster, Chris J. Twelves, S O'Reilly, Christopher J. Poole, A.M. Brunt, A-L Vallier
Publikováno v:
British Journal of Cancer
Earl, H M, Hiller, L, Dunn, J A, Vallier, A-L, Bowden, S J, Jordan, S D, Blows, F, Munro, A, Bathers, S, Grieve, R, Spooner, D A, Agrawal, R, Fernando, I, Brunt, A M, O'Reilly, S M, Crawford, S M, Rea, D W, Simmonds, P, Mansi, J L, Stanley, A, McAdam, K, Foster, L, Leonard, R C F, Twelves, C J, Cameron, D, Bartlett, J M S, Pharoah, P, Provenzano, E, Caldas, C, Poole, C J 2012, ' Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials ', British Journal of Cancer, vol. 107, no. 8, pp. 1257-1267 . https://doi.org/10.1038/bjc.2012.370
Earl, H M, Hiller, L, Dunn, J A, Vallier, A-L, Bowden, S J, Jordan, S D, Blows, F, Munro, A, Bathers, S, Grieve, R, Spooner, D A, Agrawal, R, Fernando, I, Brunt, A M, O'Reilly, S M, Crawford, S M, Rea, D W, Simmonds, P, Mansi, J L, Stanley, A, McAdam, K, Foster, L, Leonard, R C F, Twelves, C J, Cameron, D, Bartlett, J M S, Pharoah, P, Provenzano, E, Caldas, C, Poole, C J 2012, ' Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials ', British Journal of Cancer, vol. 107, no. 8, pp. 1257-1267 . https://doi.org/10.1038/bjc.2012.370
Background:\ud The National Epirubicin Adjuvant Trial (NEAT) and BR9601 trials tested the benefit of epirubicin when added to cyclophosphamide, methotrexate and 5-fluorouracil (E-CMF) compared with standard CMF in adjuvant chemotherapy for women with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a1b6ab9c6c1ed53cf274faa0f92266
https://eprints.keele.ac.uk/3177/1/bjc2012370a.pdf
https://eprints.keele.ac.uk/3177/1/bjc2012370a.pdf
Autor:
D. Jerwood, S. M. Crawford
Publikováno v:
Medical Informatics. 19:311-321
The CYVADIC combination has enjoyed popular medical support for over a decade in the treatment of soft-tissue sarcomas, and there is much documented evidence in the literature of the relative success of this and related regimens. A multivariate regre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c825fe962bb66be709220f7b1050c1a
https://doi.org/10.3109/14639239409025336
https://doi.org/10.3109/14639239409025336
The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours
Publikováno v:
British Journal of Cancer
We have studied the influence of the peripheral vasodilator hydralazine (HDZ) on the vasculature and blood perfusion of two members of a series of subcutaneous murine adenocarcinomata of the colon (MAC tumours), and the influence of HDZ on the effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::123755e3029b8de4b5ec0cc59c7a91e8
http://europepmc.org/articles/PMC1977797
http://europepmc.org/articles/PMC1977797